Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Bonner

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Seminars in Radiation Oncology|October 21, 2000
Point: the potential importance of elective nodal irradiation in the treatment of non-small cell lung cancerV Liengswangwong, J A Bonner
Biochemical and Biophysical Research Communications|January 28, 1994
Topoisomerase II-independent doxorubicin-induced cytotoxicity in an extremely doxorubicin-resistant cell lineJ A Bonner, V Liengswangwong
Brain and Cognition|August 31, 2001
Postnatal development of lateralized motor preference in the African grey parrot (Psittacus erithacus)P J Snyder, J A Bonner
Life Sciences|January 1, 1993
The interaction of etoposide with radiation: variation in cytotoxicity with the sequence of treatmentK J Minehan, J A Bonner
The British Journal of Cancer. Supplement|July 1, 1996
The interaction of buthionine sulphoximide (BSO) and the topoisomerase I inhibitor CPT-11T E Sawyer, J A Bonner
International Journal of Radiation Biology|January 1, 1990
Doxorubicin decreases the repair of radiation-induced DNA damageJ A Bonner, T S Lawrence
International Journal of Radiation Oncology, Biology, Physics|May 1, 1989
Protection of doxorubicin cytotoxicity by cycloheximideJ A Bonner, T S Lawrence
Seminars in Radiation Oncology|October 21, 2000
Postoperative irradiation in non-small cell lung cancerT E Sawyer, J A Bonner
Seminars in Radiation Oncology|October 21, 2000
Unresectable or medically inoperable non-small cell lung cancer: the use of established clinical prognostic factors in making radiation-related treatment decisionsT E Sawyer, J A Bonner
Cancer Chemotherapy and Pharmacology|January 1, 1996
The significance of the sequence of administration of topotecan and etoposideJ A Bonner, T F Kozelsky
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Seminars in Radiation Oncology|October 21, 2000
Point: the potential importance of elective nodal irradiation in the treatment of non-small cell lung cancerV Liengswangwong, J A Bonner
Biochemical and Biophysical Research Communications|January 28, 1994
Topoisomerase II-independent doxorubicin-induced cytotoxicity in an extremely doxorubicin-resistant cell lineJ A Bonner, V Liengswangwong
Brain and Cognition|August 31, 2001
Postnatal development of lateralized motor preference in the African grey parrot (Psittacus erithacus)P J Snyder, J A Bonner
Life Sciences|January 1, 1993
The interaction of etoposide with radiation: variation in cytotoxicity with the sequence of treatmentK J Minehan, J A Bonner
The British Journal of Cancer. Supplement|July 1, 1996
The interaction of buthionine sulphoximide (BSO) and the topoisomerase I inhibitor CPT-11T E Sawyer, J A Bonner
International Journal of Radiation Biology|January 1, 1990
Doxorubicin decreases the repair of radiation-induced DNA damageJ A Bonner, T S Lawrence
International Journal of Radiation Oncology, Biology, Physics|May 1, 1989
Protection of doxorubicin cytotoxicity by cycloheximideJ A Bonner, T S Lawrence
Seminars in Radiation Oncology|October 21, 2000
Postoperative irradiation in non-small cell lung cancerT E Sawyer, J A Bonner
Seminars in Radiation Oncology|October 21, 2000
Unresectable or medically inoperable non-small cell lung cancer: the use of established clinical prognostic factors in making radiation-related treatment decisionsT E Sawyer, J A Bonner
Cancer Chemotherapy and Pharmacology|January 1, 1996
The significance of the sequence of administration of topotecan and etoposideJ A Bonner, T F Kozelsky
Pageof 6